Last reviewed · How we verify

NCT03096873

Combined Resistance and Aerobic Exercise Training on Obesity in Adolescent Girls

Completed NA Results posted Last updated 3 November 2020
What this trial tests

NA trial testing Combined Exercise Training in Obesity in 40 participants. Completed in 5 June 2011.

Timeline
3 March 2011
Primary endpoint
3 June 2011
5 June 2011

Quick facts

Lead sponsorPusan National University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposehealth services research
Enrollment40
Start date3 March 2011
Primary completion3 June 2011
Estimated completion5 June 2011

Drugs / interventions tested

Conditions studied

Sponsor

Pusan National University

Who can join

Adults 14 to 16, female only, with Obesity. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Height in Meters Primary · 12 weeks

Height was measured before and after 12 weeks.

GroupValue95% CI
No Exercise (CON)1.58± 0.15
Exercise (EX)1.60± 0.11
Weight in Kilograms Primary · 12 weeks

Weight was measured before and after 12 weeks.

GroupValue95% CI
No Exercise (CON)75.8± 1.5
Exercise (EX)70.2± 2.9
BMI in Weight (Kilograms)/Height (Meters)^2 Primary · 12 weeks

BMI was calculated with weight and height before and after 12 weeks.

GroupValue95% CI
No Exercise (CON)30± 1.4
Exercise (EX)27± 2.1
Body Fat in Percents Primary · 12 weeks

Body fat was measured before and after 12 weeks.

GroupValue95% CI
No Exercise (CON)43± 2.2
Exercise (EX)39.6± 2.1
Lean Body Mass in Percents Primary · 12 weeks

Lean body mass was measured before and after 12 weeks.

GroupValue95% CI
No Exercise (CON)43± 2.2
Exercise (EX)39.6± 2.1
Waist Circumference in Centimeters Primary · 12 weeks

Waist circumference was measured before and after 12 weeks.

GroupValue95% CI
No Exercise (CON)88.2± 1.0
Exercise (EX)83.5± 0.5
Glucose Levels in Millimole Per Liter Primary · 12 weeks

Glucose levels were measured before and after 12 weeks.

GroupValue95% CI
No Exercise (CON)5.4± 0.1
Exercise (EX)4.3± 0.2
Insulin Levels in Micro Unit Per Milliliter Primary · 12 weeks

Insulin levels were measured before and after 12 weeks.

GroupValue95% CI
No Exercise (CON)27± 2.4
Exercise (EX)10.3± 2.1
Homeostasis Model Assessment of Insulin Resistance (HOMA-IR) Primary · 12 weeks

Homeostasis model assessment of Insulin Resistance (HOMA-IR) was calculated before and after 12 weeks

GroupValue95% CI
No Exercise (CON)6.5± 0.6
Exercise (EX)1.9± 0.7
Leptin Levels in Nano Grams Per Milliliter Primary · 12 weeks

Leptin levels were measured before and after 12 weeks.

GroupValue95% CI
No Exercise (CON)22.5± 2.3
Exercise (EX)12.8± 1.4
Adiponectin Levels in Micro Grams Per Milliliter Primary · 12 weeks

Adiponectin levels were measured before and after the training.

GroupValue95% CI
No Exercise (CON)5.7± 0.5
Exercise (EX)8.5± 0.1
Volume of Maximal Oxygen Consumption (VO2max) Secondary · 12 weeks

Volume of maximal oxygen consumption (VO2max) was determined using a maximal treadmill test before and after 12 weeks.

GroupValue95% CI
No Exercise (CON)26± 2.1
Exercise (EX)27± 1.2

Sponsor's own description

The purpose of the study was to observe therapeutic effects of combined resistance and aerobic exercise training (CRAE) on hyperinsulemia in obese adolescent girls. Forty obese adolescent girls (14±1 years) participated in this study. The participants were randomly separated into two groups; no-exercise group (n=20) and exercise group (n=20). The exercise group performed 12 weeks of CRAE.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Combined Exercise Training

Trials testing the same drug.

Other recruiting trials for Obesity

Currently open trials in the same condition.

Other Pusan National University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03096873.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing